{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-026853","form_type":"8-K","ticker":"IRD","cik":"0001228627","company_name":"Opus Genetics, Inc.","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.526722+00:00","generated_at":"2026-05-18T03:14:15.961647+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Opus Genetics partners with Global RDH12 Alliance for OPGx-RDH12; $1.6M funding","bullets":["Agreement with RDH12 Fund for Sight and Eyes on the Future provides up to $1.6M for OPGx-RDH12 development.","Partnership includes risk-sharing structure and performance-based milestones; IND filing targeted by late 2025.","If milestones missed, Funding Parties can exercise a non-exclusive license; Opus retains right to negotiate exclusive license back.","During term, Opus cannot grant exclusive U.S. license to a third party without Funding Parties' consent.","Term ends upon dosing three patients in Phase 1a/2b or first commercial sale, or if exclusive global licensee assumes obligations."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-026853","json":"https://secwatch.observer/filing/0001140361-25-026853.json","markdown":"https://secwatch.observer/filing/0001140361-25-026853.md","text":"https://secwatch.observer/filing/0001140361-25-026853.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1228627/000114036125026853/0001140361-25-026853-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1228627/000114036125026853/ef20052404_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T03:14:15.961647+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}